Research Into Aging Reveals Intriguing Compounds
A new screening approach developed in the lab of William Ja, Ph.D. is offering a new way to study the biology of aging.
A new screening approach developed in the lab of William Ja, Ph.D. is offering a new way to study the biology of aging.
The documentary, “The Resilient Brain,” explores the complexity of the human brain across the lifespan, and features neuroscientists including Gavin Rumbaugh, Ph.D., of The Wertheim UF Scripps Institute.
Neuroscientist Jinyoung Kang’s research aims to help millions of people with conditions that involve dysregulated brain signaling, including Alzheimer’s, Parkinson’s, epilepsy and autism.
"These grants highlight The Wertheim UF Scripps Institute’s unique expertise in areas that include neuroscience, immunology, biochemistry, drug discovery and RNA therapeutics,” said Scientific Director Patrick Griffin, Ph.D.
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.
One in five of our faculty holds a prestigious R35 Outstanding Investigator Award from the National Institutes of Health.
Nearly 600 students applied for 10 Summer Undergraduate Research Fellows internship slots this year, said Rosie Albarran Zeckler, Ph.D. Meet the 2025 college interns.
A gene called Syngap1 enables touch-based perception, while certain mutations can lead to mixed signals, a new study finds.
Two public panel discussions in Jupiter, Florida, will explore new discoveries about the brain and brain health.
A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.